UNSPSC 51373451: Codeine/terpin hydrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373451 Codeine/terpin hydrate is a Commodity code that in recent state and local procurement activity covers naloxone, drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers to government health and human services agencies. State and local buyers under this code include county public health departments, state pharmacy and pharmaceutical procurement offices, and multistate cooperative purchasing alliances that source on behalf of participating jurisdictions. The work involves supplying finished pharmaceutical products with specified National Drug Codes, dosage forms, and packaging configurations; managing inventory and quarterly or regular delivery schedules to designated facilities; and maintaining compliance with FDA regulations, cGMP standards, the Drug Supply Chain Security Act, and federal environmental and workplace requirements.

Recent activity spans Florida and Minnesota with multistate reach through cooperative purchasing vehicles. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with bids due July 26, 2023 (note: the due date appears to be a data entry error in the source, as the posting date is June 30, 2026). The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 for multiple contracts covering generic pharmaceuticals and OTC products to be supplied through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.) to participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions; proposals were due March 26, 2026, with contract effectiveness July 1, 2026. Pricing is weighted heavily toward competitiveness (75 percent), with vendors required to maintain $5,000,000 commercial general liability insurance and accept a 3 percent administrative fee on all purchases.